ross river virus
Ross River virus (RRV) is a small encapsulated single-strand RNA Alphavirus endemic to Australia, Papua New Guinea and other islands in the South Pacific. It is responsible for a type of mosquito-borne, non-lethal but extremely debilitating tropical disease known as Ross River fever, previously termed "epidemic polyarthritis". There is no known cure, and it can last in the host's system 35 years and continue to go with very painful strong remainders 2 or 3 times per year. The virus is suspected to be enzootic in populations of various native Australian mammals, and has been found on occasion in horses. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Earliest trial started Jun 1, 2008 (NCT00717834)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Ross River virusImmunity, active
immunity, active - ross river virus
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaRoss River virus ↗
Also known as
- ross river virus
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00717834 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2008 | Ology Bioservices |
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ology Bioservices | For profit | 1 | 1 | 1 | 2008 |